Voyager Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Voyager Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 511% to $250,008,000. The net income raised on $132,330,000 and profit margin reached 53%. Total operating expenses were $127,994,000.
Profit Margin
| 2014 | 0 | -16.31M | |
|---|---|---|---|
| 2015 | 17.33M | -29.67M | -171.18% |
| 2016 | 14.22M | -40.19M | -282.65% |
| 2017 | 10.13M | -70.69M | -697.56% |
| 2018 | 7.61M | -88.28M | -1158.79% |
| 2019 | 104.39M | -40.83M | -39.11% |
| 2020 | 171.12M | 36.74M | 21.47% |
| 2021 | 37.41M | -66.03M | -176.49% |
| 2022 | 40.90M | -46.40M | -113.45% |
| 2023 | 250.00M | 132.33M | 52.93% |
VYGR Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 250.00M | 40.90M | 37.41M | 171.12M | 104.39M | 7.61M | 10.13M | 14.22M | 17.33M | 0 |
Cost of revenue | 4.44M | 6.19M | 73.78M | 108.75M | 119.73M | 0 | 62.26M | 0 | 27.67M | 8.89M |
Gross profit | 245.56M | 34.71M | -36.37M | 62.37M | -15.34M | 7.61M | -52.12M | 14.22M | -10.34M | -8.89M |
Operating exp. | ||||||||||
Research and development | 92.17M | 60.76M | 73.78M | 108.75M | 119.73M | 64.90M | 62.26M | 42.24M | 27.67M | 8.89M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 127.99M | 91.74M | 111.03M | 143.74M | 156.07M | 98.71M | 81.99M | 55.51M | 37.58M | 14.36M |
Operating income | 122.01M | -50.83M | -73.61M | 27.38M | -51.67M | -91.09M | -71.86M | -41.29M | -20.25M | -14.36M |
Other income (expenses), net | 11.72M | 4.44M | 2.42M | 9.35M | 8.08M | 2.62M | 1.16M | 1.15M | -9.41M | -1.95M |
Income before tax | 133.73M | -46.39M | -71.19M | 36.74M | -43.59M | -88.46M | -70.69M | -40.14M | -29.67M | -16.31M |
Income tax expense | 1.40M | 16K | -5.16M | -1.65M | -2.76M | -180K | -1.59M | 52K | -600K | 0 |
Net income | 132.33M | -46.40M | -66.03M | 36.74M | -40.83M | -88.28M | -70.69M | -40.19M | -29.67M | -16.31M |
Earnings per share | ||||||||||
Basic EPS | 3.08 | -1.21 | -1.75 | 0.99 | -1.14 | -2.75 | -2.64 | -1.59 | -7.08 | -1.11 |
Diluted EPS | 2.97 | -1.21 | -1.75 | 0.98 | -1.14 | -2.75 | -2.64 | -1.59 | -7.08 | -1.11 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |